A coalition of consumer advocacy, free market, and drug policy reform groups oppose measures to prohibit and ban kratom-derived 7-OH products. WASHINGTON, DC – A diverse coalition of consumer advocacy...
WASHINGTON, D.C. – Today, the Consumer Choice Center launched a new policy primer offering smart approaches and a regulatory framework for 7-OH and kratom derivatives, a series of compounds and...
Today the FDA issued a highly anticipated ban on Red Dye No. 3 as a color additive for food and ingested drugs. In their public statement, the FDA says in the...
Washington, D.C. – The U.S. Supreme Court today heard oral arguments in FDA v. Wages and White Lion Investments, LLC, a pivotal case concerning the Food and Drug Administration’s rejection of...
If we are to realize the kind of aggressive, innovation-promoting deregulation called for by President Trump, Stephen Hahn (FDA) will need to disrupt the agency’s built-in bias for overregulation. Now...
